Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™) [Phase 2]
Phase 2 trial of CyCol, an oral colonic-release ciclosporin, for mild to moderate ulcerative colitis has been completed.
-
CLINICAL_TRIALS trial_result · 2012-04-04Clinical Trial Update: Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis [Phase 3]
A Phase 3 pediatric trial assessing the safety and efficacy of Asacol (mesalamine) given every 12 hours in children and adolescents with act…
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis [NA]
This document reports the completion of the pediatric ADAPT Adacolumn trial for ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis [Phase 2]
A Phase 2 safety and efficacy study of bovine intestinal alkaline phosphatase in patients with moderate to severe ulcerative colitis has com…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease [Phase 2]
Phase 2 clinical study of HuZAF, a humanized anti-Interferon-γ monoclonal antibody, for moderate-to-severe Crohn's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis [Phase 2, Phase 3]
A Phase 2/Phase 3 study of visilizumab for intravenous steroid-refractory ulcerative colitis was terminated.
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study [Phase 2, Phase 3]
Clinical trial update indicating a terminated Phase 2/Phase 3 study comparing visilizumab to placebo in intravenous steroid-refractory ulcer…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis [Phase 1, Phase 2]
Update on a Visilizumab trial in severe ulcerative colitis spanning Phase 1 and Phase 2, which has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Research Study in Patients With Severe Ulcerative Colitis [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating a treatment for severe ulcerative colitis sponsored by Facet Biotech.
-
CLINICAL_TRIALS research · 2012-02-27Clinical Trial Update: Mind/Body Medicine and IBD Flare-Up [Phase 1]
This clinical trial update summarizes a Phase 1 study exploring mind/body medicine for ulcerative colitis flare-ups, conducted by Rush Unive…
-
FDA approval · 2011-12-26FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2011-12-16Clinical Trial Update: Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807) [Phase 3]
A Phase 3 trial comparing infliximab monotherapy, infliximab plus azathioprine, and azathioprine monotherapy for maintaining remission in ul…
-
CLINICAL_TRIALS trial_result · 2011-12-16Clinical Trial Update: Cannabis for Inflammatory Bowel Disease [Phase 1, Phase 2]
A clinical trial update describes Phase 1/Phase 2 studies evaluating cannabis for inflammatory bowel disease, including Crohn's disease and …
-
CLINICAL_TRIALS research · 2011-12-14Clinical Trial Update: Durability and Tolerability of Infliximab in Pediatric Inflammatory Bowel Disease Patients: A 10 Year Single Center Experience
A 10-year single-center observational update evaluating the durability and tolerability of infliximab in pediatric inflammatory bowel diseas…
-
FDA approval · 2011-12-13FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Role of Healthy Bacteria in Ulcerative Colitis [Phase 4]
A Phase 4 trial update investigates the role of healthy gut bacteria in Ulcerative Colitis; the current study status is unknown.
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: Chromoendoscopy for Ulcerative Colitis Surveillance
A clinical trial update indicates that the chromoendoscopy surveillance study for ulcerative colitis has completed. The study included parti…
-
CLINICAL_TRIALS trial_result · 2011-11-16Clinical Trial Update: A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial is investigating the efficacy of LT-02 in patients with mesalazine-refractory ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2011-11-08Clinical Trial Update: PillCam Colon Capsule Endoscopy for Ulcerative Colitis
The clinical trial evaluating PillCam Colon Capsule Endoscopy for Ulcerative Colitis has completed.
-
FDA approval · 2011-09-07FDA Approved: SIMPONI — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for SIMPONI (golimumab) filed by Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2011-08-31Clinical Trial Update: Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis [Phase 4]
A Phase 4 trial comparing cyclosporine with infliximab for steroid-refractory severe ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-16Clinical Trial Update: Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis
This clinical trial update notes the completion of a follow-up study evaluating a retarded-release phosphatidylcholine formulation for ulcer…
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)
An update on a completed clinical trial evaluating endocytoscopy for in vivo determination of mucosal inflammatory cells and intestinal dise…
-
CLINICAL_TRIALS trial_result · 2011-08-11Clinical Trial Update: The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation [Phase 4]
Phase 4 clinical trial update examining whether probiotics affect recovery in inflammatory bowel disease, endothelial function, and inflamma…
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of infliximab (Remicade) in pediatric patients with moderately to severely activ…